Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    -25.00 (-0.45%)
Bid:
5,500.00
Ask:
5,550.00
Spread: 50.00 (0.909%)
Market Cap: £139.03m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

8 Mar 2023 07:00

RNS Number : 2183S
Camellia PLC
08 March 2023
 

8 March 2023

Camellia Plc

(the "Company" or the "Group")

 

Trading update

 

Further to the trading announcement on 7 December there has been a significant improvement to our expectations for underlying profit before tax for the Group for 2022.

 

Negotiations on pay in Bangladesh have now concluded resulting in a government mandated payment of Tk11,000 per permanent worker (payable during 2023) and a pay increase of 41.7% effective from the beginning of August 2022. This is a significantly improved outcome than anticipated and will be reflected in our 2022 results.

 

In addition, trading in our agriculture division in the final quarter of the year has been ahead of our expectations due to:

· Higher net sales prices achieved for India, Bangladesh and Kenya teas

· Better net sales prices for avocados

· Improved net sales prices achieved for both soya and maize

· Tighter control of production and overhead costs across the division

· Offset in part by lower net sales prices for macadamia and Malawi teas

 

We also further reduced our head office overhead costs.

 

Revenue for continuing operations* for 2022 is now expected to be approximately £294 million. As a consequence of the factors set out above, excluding any financial results for BF&M for 2022, the Company now believes that the adjusted profit before tax for continuing operations** for the Group for 2022 will be approximately 10% below the reported adjusted profit before tax for continuing operations (including BF&M share of results for that year) for 2021 which was £8.8 million. This compares very favourably to the Company's previous guidance given on 7 December 2022.

 

BF&M is expected to announce its results in April 2023 and until that time, as a consequence of the impact of the volatility of equity and bond markets on BF&M's results, it is not possible for Camellia to forecast the likely full year outcome for BF&M with any certainty.

 

 

* continuing operations are all operations except for ACS&T which was sold at the end of 2022

** adjusted profit before tax for continuing operations seeks to present an indication of performance for continuing operations which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges, gains/losses on disposal of assets and restructuring costs.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGGFMNMGFZZ
Date   Source Headline
4th May 20079:39 amRNSAnnual Report and Accounts
26th Apr 20071:00 pmRNSFinal Results
18th Apr 20074:44 pmRNSDisposal of investment
18th Apr 20074:39 pmRNSHolding(s) in Company
13th Apr 20073:54 pmRNSKakuzi Limited
20th Dec 20061:56 pmRNSTotal Voting Rights
13th Oct 20063:26 pmRNSTransaction in Own Shares
5th Oct 200610:21 amRNSInterim Report
28th Sep 200612:30 pmRNSInterim Results
27th Sep 200610:09 amRNSAcquisition
11th Aug 20062:29 pmRNSAcquisition
28th Jul 20069:27 amRNSDirectorate Change
12th Jun 200610:52 amRNSResult of AGM
8th Jun 200612:16 pmRNSAGM Statement
7th Jun 200610:31 amRNSAnnual Information Update
8th May 20064:17 pmRNSReport and accounts 2005
27th Apr 20064:05 pmRNSFinal Results
25th Nov 200510:37 amRNSDirectorate Change
18th Nov 20053:21 pmRNSHolding(s) in Company
18th Nov 20052:42 pmRNSDirector/PDMR Sharehldg-Rep
17th Nov 20053:44 pmRNSHolding(s) in Company
17th Nov 20053:43 pmRNSDirector/PDMR Shareholding
17th Nov 20057:01 amRNSAdditional Listing
14th Nov 200512:05 pmRNSStmt re Additional Listing
14th Nov 200512:00 pmRNSResult of Court Hearing
31st Oct 200511:42 amRNSResult of Court Meeting
31st Oct 200511:34 amRNSResult of EGM
30th Sep 200510:40 amRNSEPT Disclosure
29th Sep 20054:43 pmRNSCircular and Interim Report
28th Sep 20057:03 amRNSOffer for Linton Park Plc
28th Sep 20057:02 amRNSOffer for Linton Park Plc
28th Sep 20057:00 amRNSInterim Results
15th Sep 20054:44 pmRNSHolding(s) in Company
15th Sep 20054:34 pmRNSTransfer of Shares
9th Sep 200511:30 amRNSEPT Disclosure
5th Sep 200510:45 amRNSEPT Disclosure
1st Sep 200511:55 amRNSEPT Disclosure
30th Aug 200510:48 amRNSEPT Disclosure
26th Aug 200510:59 amRNSEPT Disclosure
26th Aug 200510:59 amRNSRule 8.3 - Camellia plc
24th Aug 200510:39 amRNSEPT Disclosure
19th Aug 200510:35 amRNSEPT Disclosure
18th Aug 200511:26 amRNSEPT Disclosure
16th Aug 20055:51 pmRNSEPT Disclosure
16th Aug 200510:12 amRNSEPT Disclosure
15th Aug 200510:54 amRNSEPT Disclosure
9th Aug 200510:59 amRNSEPT Disclosure
5th Aug 200510:56 amRNSEPT Disclosure
4th Aug 200510:13 amRNSEPT Disclosure
3rd Aug 200511:51 amRNSRule 8.3- Camellia plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.